Flaxseed Lignan Supplementation in Elderly Participants With Stage I Hypertension

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 100 participants.

Also called NCT02391779

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02391779
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02391779. Randomized; double masking; primary purpose treatment. Start 2015-05 (registry gives no type); primary completion 2017-07 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Flaxseed Lignan Supplementation in Elderly Participants With Stage I Hypertension
Condition
Hypertension
Intervention (Dietary supplement)
BeneFlax®
Intervention (Behavioral)
Walking training
Intervention (Behavioral)
Flexibility training
Intervention (Dietary supplement)
Placebo (Whey Protein)
Intervention (Behavioral)
Dash Eating Plan
Lead sponsor
University of Saskatchewan (class: other)

Record details

Record id
cardio:ct-nct02391779
Content hash
ceba3246c46d0a08aeb5a82636da4dd7b9ae07254c439f51aba22f5c92e7d1e6